相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
Helene Marijon et al.
JOURNAL OF HEPATOLOGY (2011)
Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes
Bo Tang et al.
MEDICAL ONCOLOGY (2011)
Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients
Monique M. Nijkamp et al.
RADIOTHERAPY AND ONCOLOGY (2011)
E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
Jan Theys et al.
RADIOTHERAPY AND ONCOLOGY (2011)
A Differentiation-Based MicroRNA Signature Identifies Leiomyosarcoma as a Mesenchymal Stem Cell-Related Malignancy
Laura S. Danielson et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Hepatocyte Growth Factor Induces Invasion and Migration of Ovarian Cancer Cells by Decreasing the Expression of E-Cadherin, β-Catenin, and Caveolin-1
Jun Hu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases
Marlo M. Nicolas et al.
HUMAN PATHOLOGY (2010)
The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
Stine Lyngvi Fougner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
Chad J. Creighton et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome
Lai-Kui Liu et al.
MODERN PATHOLOGY (2010)
Integrated Proteomics and Genomics Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of Slug
Jilong Yang et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling
A. H. Beck et al.
ONCOGENE (2010)
Expression of E-cadherin, β-catenin and topoisomerase IIα in leiomyosarcomas
Pinelopi N. Gogou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer
Kristine Ansenberger et al.
GYNECOLOGIC ONCOLOGY (2009)
The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer
Ja Seung Koo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma
Athanasios C. Tsiatis et al.
MODERN PATHOLOGY (2009)
The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
S. Al-Saad et al.
BRITISH JOURNAL OF CANCER (2008)
World Health Organization classification of bone and soft tissue tumors: Modifications and implications for radiologists
Mark D. Murphey
SEMINARS IN MUSCULOSKELETAL RADIOLOGY (2007)
Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group
Catarina Svarvar et al.
CANCER (2007)
Epitheliold leiomyosarcoma of the uterine cervix: A case report and review of the literature
M Toyoshima et al.
GYNECOLOGIC ONCOLOGY (2005)
E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components
FX Bosch et al.
INTERNATIONAL JOURNAL OF CANCER (2005)